Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126104262 | 12610426 | 2 | F | 20160809 | 20160801 | 20160812 | EXP | PHHY2016BR104782 | NOVARTIS | 0.00 | M | Y | 105.00000 | KG | 20160812 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126104262 | 12610426 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 3 DF, QD | 20234 | 3 | DF | EXTENDED RELEASE TABLET | QD | ||||||
| 126104262 | 12610426 | 2 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | 3 DF, QD | 0 | 3 | DF | QD | |||||||
| 126104262 | 12610426 | 3 | C | FRISIUM | CLOBAZAM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126104262 | 12610426 | 1 | Brain neoplasm |
| 126104262 | 12610426 | 2 | Seizure |
| 126104262 | 12610426 | 3 | Seizure |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126104262 | 12610426 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126104262 | 12610426 | 1 | 201401 | 0 | ||
| 126104262 | 12610426 | 2 | 201401 | 0 | ||
| 126104262 | 12610426 | 3 | 201401 | 0 |